The Wilf Family Cardiovascular Research Institute, Department of Medicine, Cardiology (L.A., I.T., S.C.H., A.H., H.V., C.H., A.K., K.S., N.G.F.), Albert Einstein College of Medicine, Bronx, NY.
Departments of Microbiology and Immunology (L.A., I.T., S.C.H., A.H., H.V., C.H., A.K., K.S., N.G.F.), Albert Einstein College of Medicine, Bronx, NY.
Circulation. 2023 Sep 12;148(11):882-898. doi: 10.1161/CIRCULATIONAHA.123.064155. Epub 2023 Jun 23.
Pericytes have been implicated in tissue repair, remodeling, and fibrosis. Although the mammalian heart contains abundant pericytes, their fate and involvement in myocardial disease remains unknown.
We used NG2;PDGFRα pericyte:fibroblast dual reporter mice and inducible NG2 mice to study the fate and phenotypic modulation of pericytes in myocardial infarction. The transcriptomic profile of pericyte-derived cells was studied using polymerase chain reaction arrays and single-cell RNA sequencing. The role of transforming growth factor-β (TGF-β) signaling in regulation of pericyte phenotype was investigated in vivo using pericyte-specific TGF-β receptor 2 knockout mice and in vitro using cultured human placental pericytes.
In normal hearts, neuron/glial antigen 2 (NG2) and platelet-derived growth factor receptor α (PDGFRα) identified distinct nonoverlapping populations of pericytes and fibroblasts, respectively. After infarction, a population of cells expressing both pericyte and fibroblast markers emerged. Lineage tracing demonstrated that in the infarcted region, a subpopulation of pericytes exhibited transient expression of fibroblast markers. Pericyte-derived cells accounted for ~4% of PDGFRα+ infarct fibroblasts during the proliferative phase of repair. Pericyte-derived fibroblasts were overactive, expressing higher levels of extracellular matrix genes, integrins, matricellular proteins, and growth factors, when compared with fibroblasts from other cellular sources. Another subset of pericytes contributed to infarct angiogenesis by forming a mural cell coat, stabilizing infarct neovessels. Single-cell RNA sequencing showed that NG2 lineage cells diversify after infarction and exhibit increased expression of matrix genes, and a cluster with high expression of fibroblast identity markers emerges. Trajectory analysis suggested that diversification of infarct pericytes may be driven by proliferating cells. In vitro and in vivo studies identified TGF-β as a potentially causative mediator in fibrogenic activation of infarct pericytes. However, pericyte-specific TGF-β receptor 2 disruption had no significant effects on infarct myofibroblast infiltration and collagen deposition. Pericyte-specific TGF-β signaling was involved in vascular maturation, mediating formation of a mural cell coat investing infarct neovessels and protecting from dilative remodeling.
In the healing infarct, cardiac pericytes upregulate expression of fibrosis-associated genes, exhibiting matrix-synthetic and matrix-remodeling profiles. A fraction of infarct pericytes exhibits expression of fibroblast identity markers. Pericyte-specific TGF-β signaling plays a central role in maturation of the infarct vasculature and protects from adverse dilative remodeling, but it does not modulate fibrotic remodeling.
周细胞在组织修复、重塑和纤维化中起作用。虽然哺乳动物心脏含有丰富的周细胞,但它们的命运及其在心肌疾病中的作用仍不清楚。
我们使用 NG2;PDGFRα 周细胞:成纤维细胞双重报告小鼠和诱导型 NG2 小鼠研究心肌梗死中周细胞的命运和表型调节。使用聚合酶链反应阵列和单细胞 RNA 测序研究周细胞衍生细胞的转录组谱。通过体内使用周细胞特异性 TGF-β 受体 2 敲除小鼠和体外使用培养的人胎盘周细胞,研究转化生长因子-β(TGF-β)信号在调节周细胞表型中的作用。
在正常心脏中,神经元/神经胶质抗原 2(NG2)和血小板衍生生长因子受体α(PDGFRα)分别鉴定出周细胞和成纤维细胞的不同非重叠群体。梗死后,出现了一种同时表达周细胞和成纤维细胞标志物的细胞群体。谱系追踪表明,在梗死区域,亚群周细胞短暂表达成纤维细胞标志物。在修复的增殖期,周细胞衍生细胞约占 PDGFRα+梗死成纤维细胞的 4%。与其他细胞来源的成纤维细胞相比,周细胞衍生的成纤维细胞表达更高水平的细胞外基质基因、整合素、基质细胞蛋白和生长因子,活性更高。另一亚群周细胞通过形成壁细胞外套来促进梗死血管生成,稳定梗死新生血管。单细胞 RNA 测序表明,NG2 谱系细胞在梗死后发生多样化,并表现出基质基因表达增加,出现一个高表达成纤维细胞特征标志物的簇。轨迹分析表明,梗死周细胞的多样化可能是由增殖细胞驱动的。体内和体外研究表明,TGF-β可能是导致梗死周细胞成纤维样激活的潜在致病介质。然而,周细胞特异性 TGF-β 受体 2 缺失对梗死肌成纤维细胞浸润和胶原沉积没有显著影响。周细胞特异性 TGF-β 信号参与血管成熟,介导梗死新生血管的壁细胞外套形成并保护其免受扩张性重塑。
在愈合的梗死中,心脏周细胞上调纤维化相关基因的表达,表现出基质合成和基质重塑特征。梗死周细胞的一部分表现出成纤维细胞特征标志物的表达。周细胞特异性 TGF-β 信号在梗死血管成熟中起核心作用,并防止不利的扩张性重塑,但不调节纤维化重塑。